Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules
NCT04171492 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2025-09-19
Summary
This study evaluates the how addition of the Nodify XL2 test result impacts the clinical management of newly identified solid lung nodules assessed as low to moderate risk of cancer.
Conditions
- Nodule Solitary Pulmonary
- Non-small Cell Carcinoma
Sponsors & Collaborators
-
Biodesix, Inc.
lead INDUSTRY
Principal Investigators
-
Steven Springmeyer · Biodesix, Inc.
-
Gerard Silvestri, MD · Medical University of South Carolina
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-18
- Primary Completion
- 2025-12-31
- Completion
- 2026-12-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
New Method to Differentiate Benign and Malignant Pulmonary Nodules.
NCT06056999 ·Status: RECRUITING
-
MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
NCT05699213 ·Status: RECRUITING
-
A Multi-Center Trial of the ProLung Test™
NCT01566682 ·Status: COMPLETED
-
Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer
NCT01958931 ·Status: COMPLETED
-
Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
NCT07047573 ·Status: RECRUITING
-
Real-Time Non-Invasive Localization for Multiple Lung Nodules
NCT07257549 ·Status: COMPLETED ·Phase: NA
-
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
NCT03633006 ·Status: COMPLETED
-
Clinical Study of ctDNA and Exosome Combined Detection to Identify Benign and Malignant Pulmonary Nodules
NCT04182893 ·Status: UNKNOWN
-
Diagnostic Study for Lung Cancer Detection Test
NCT01700452 ·Status: COMPLETED
-
A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
NCT06074133 ·Status: ACTIVE_NOT_RECRUITING
-
Pulmonary Nodule Cohort
NCT04049422 ·Status: NOT_YET_RECRUITING
-
Utility of CAML as Diagnostic for Early Stage Lung Cancer
NCT03992183 ·Status: TERMINATED
-
Clinical Investigation Evaluating the Performance, Safety and Clinical Benefit of the Endowave FlexAblate™ Microwave Ablation System in Patients Undergoing Lung Ablation Procedures.
NCT07291973 ·Status: RECRUITING ·Phase: NA
-
Localization for Deep Lung Nodules: Microcoil Versus Contrast Injection
NCT03617029 ·Status: UNKNOWN ·Phase: NA
-
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
NCT06518655 ·Status: RECRUITING
-
Evaluating the Pulmonary Nodule With Imaging and Biomarkers
NCT01739881 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis in Patients With Known Lung Nodules
NCT02075320 ·Status: COMPLETED ·Phase: NA
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
NCT07168993 ·Status: RECRUITING ·Phase: NA
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
Chest Imaging, Breath, and Biomarkers in a Screening Trial
NCT01663155 ·Status: COMPLETED
-
Molecular Signature From Tumor to Lymph Nodes
NCT04677205 ·Status: RECRUITING
-
DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
NCT02504697 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarker Discovery in Lung Cancer - Malaysia
NCT06504927 ·Status: RECRUITING
-
Circulating Tumor DNA Methylation Test to Differentiate Benign and Malignant Pulmonary Nodules
NCT03181490 ·Status: COMPLETED